Curaleaf Holdings (CURLF) Non-Current Assets (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Non-Current Assets of $2.4 billion for Q4 2025, down 4.72% year-on-year from $2.5 billion in Q4 2024, and down 4.72% on a QoQ basis from $2.5 billion in Q4 2024.

Curaleaf Holdings (CURLF) Non-Current Assets (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Non-Current Assets for 7 consecutive years, with $2.4 billion the latest figure, recorded in Q4 2025.

  • Quarterly Non-Current Assets fell 4.72% year-over-year to $2.4 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.2 billion (down 3.27% YoY) and the FY2025 annual result came in at $2.4 billion, down 4.72% from the prior year.
  • Non-Current Assets declined to $2.4 billion in Q4 2025 per CURLF's latest filing, from $2.5 billion in the prior quarter.
  • Over the last five years, Non-Current Assets for CURLF reached as high as $2.8 billion in Q2 2023 and fell as low as -$974.4 billion in Q1 2022.
  • A 5-year average of -$63.3 billion and a median of $2.4 billion in 2023 frame the typical range for Non-Current Assets.
  • The largest YoY upside for Non-Current Assets was 23569.62% in 2022 against a maximum downside of 49767.67% in 2022.
  • Year by year, Non-Current Assets stood at $10.4 million in 2021, then jumped by 23569.62% to $2.5 billion in 2022, then declined by 3.69% to $2.4 billion in 2023, then climbed by 6.08% to $2.5 billion in 2024, then fell by 4.72% to $2.4 billion in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $2.4 billion, $2.5 billion, and $2.7 billion for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 2.40 Bn
Dec 31, 2024 2.52 Bn
Sep 30, 2024 2.65 Bn
Jun 30, 2024 2.66 Bn
Dec 31, 2023 2.37 Bn
Sep 30, 2023 2.74 Bn
Jun 30, 2023 2.84 Bn
Dec 31, 2022 2.46 Bn
Sep 30, 2022 -920.77 Mn
Jun 30, 2022 -933.63 Mn
Mar 31, 2022 -974.43 Bn
Dec 31, 2021 10.40 Mn
Sep 30, 2021 2.27 Bn
Jun 30, 2021 2.35 Bn
Mar 31, 2021 1.96 Bn
Dec 31, 2020 1.95 Bn
Sep 30, 2020 1.98 Bn
Dec 31, 2019 587.40 Mn